Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06690255 · ClinicalTrials.gov registry record · NA

Trial of an Online Spanish Pivotal Response Treatment Training in Autism Spectrum Disorder

A NA study, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target

NCT06690255: Recruiting NA study, sponsored by Stanford University.

NCT06690255 is a NA study that is actively recruiting participants, run by Stanford University. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06690255, a NA study, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The goal of this clinical trial is to understand if an online course in Spanish can help Spanish-speaking parents use Pivotal Response Treatment (PRT) to support language and social skills in young children with Autism Spectrum Disorder (ASD). This study aims to reach families who may have trouble accessing autism services due to language, location, or cost barriers. The main questions it hopes to answer are: * Can Spanish-speaking parents learn to effectively use PRT techniques to support their child's communication? * Does this training improve children's language and social interactions? Researchers will evaluate the effectiveness of the online course for parents who participate in regular virtual check-ins and submit videos showing their practice with PRT. Participants in the study will: * Complete online lessons over 12 weeks that teach PRT methods, specifically designed for Spanish-speaking parents * Meet with a research team member every few weeks by phone or video to ask questions and receive feedback * Provide video recordings of interactions with their child to track progress * Complete brief surveys about their experience and child's communication abilities By focusing on Spanish-speaking families, this study aims to increase access to effective autism support and reduce gaps in care. Researchers hope the findings will help develop better resources for families facing similar barriers and improve language and social outcomes for children with autism.

Primary Outcome

Based on behavioral coding of parent-child interaction videos in the home

Interventions

  • BEHAVIORAL Pivotal Response Treatment

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-06-17
Est. Completion 2030-12-15
Phase NA
Stanford University

1,744 total trials

What NCT06690255 shows while recruiting

NCT06690255 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Pivotal Response Treatment is the first listed.

NCT06690255 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06690255 about?

NCT06690255 is a clinical study titled "Trial of an Online Spanish Pivotal Response Treatment Training in Autism Spectrum Disorder". The goal of this clinical trial is to understand if an online course in Spanish can help Spanish-speaking parents use Pivotal Response Treatment (PRT) to support language and social skills in young children with Autism Spectrum Disorder (ASD). This study aims to reach families who may have trouble a...

What is the current status of trial NCT06690255?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-06-17. Estimated completion is 2030-12-15.

What interventions are being tested in trial NCT06690255?

The interventions under investigation include: Pivotal Response Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT06690255?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06690255's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06690255, the US trial registry maintained by the National Library of Medicine. NCT06690255 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.